Fundz

Neuraxis Secures $3 Million Financing

PUBLIC · NRXSNov 14, 2023

Amount Raised

$3 Million

Round Type

Seed

CarmelBiotechnologyHealth CareMedicalMedical Device

Description

NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced it has secured a $3 million financing for NeurAxis through a preferred stock offering priced at $2.38 per share.

Quick answer

NeurAxis raised $3 Million in a Seed round, dated November 14, 2023. NeurAxis is based in Carmel, Indiana, United States.

How much did NeurAxis raise?
NeurAxis raised $3 Million in a Seed round on November 14, 2023.
What does NeurAxis do?
NeurAxis, Inc. is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults.
Where is NeurAxis based and how big is it?
NeurAxis is based in Carmel, Indiana, United States. Fundz records about 32 employees.
Who are the decision-makers at NeurAxis?
Fundz holds 2 contacts at NeurAxis. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as NeurAxis that raised within 45 days of this round, from Fundz verified event records.

  • Nalu Medical raised $115M on December 21, 2023.
  • Procyrion raised $58M on December 13, 2023.
  • Laza Medical raised $36M (Series A) on December 12, 2023.
  • INTRINSIC THERAPEUTICS raised $55M on November 30, 2023.
  • Laza Medical raised $25M on November 24, 2023.
  • Tenon Medical raised $1.3M (Seed) on November 21, 2023.

Who to call at NeurAxis, and when

A new round usually means NeurAxis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NeurAxis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NeurAxis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NeurAxis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NeurAxis

Location

Carmel, Indiana, United States

About

NeurAxis, Inc. is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. The company is dedicated to advancing science and leveraging evidence-based medicine to drive adoption of its IB-Stim™ therapy, which is its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NeurAxis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for NeurAxis's next move

See what Strategic adds

NeurAxis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.